Studies on the effect of feeding anti-CD3 Antibody in the prevention and treatment of colitis

饲喂抗CD3抗体防治结肠炎效果的研究

• 批准号: 175661
• 负责人: Forster Katharina
• 金额: $ 8.74万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2008
• 资助国家: 加拿大
• 起止时间: 2008-10-01 至 2010-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=175661&lang=en
• 关键词: Animal Models; Ibd; Musosal Immunology; Musosal Inflammation; Oral Tolerance; Regulatory Tcell; T Cell

Over 200,000 Canadians suffer from inflammatory bowel diseases (IBD) such as Crohn¿s disease (CD) or ulcerative colitis (UC). To date there are no known treatments to cure the disease. Although the cause of IBD is unknown, the theory is that IBD has a ge

超过20万加拿大人患有炎症性肠病（IBD），如克罗恩病（CD）或溃疡性结肠炎（UC）。迄今为止，还没有已知的治疗方法可以治愈这种疾病。 虽然IBD的病因尚不清楚，但理论上认为IBD具有遗传性。